FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083790519> ?p ?o ?g. }

• W2083790519 endingPage "1214" @default.
• W2083790519 startingPage "1205" @default.
• W2083790519 abstract "Abnormal expression of solute carrier family 34 (sodium phosphate), member 2 (SLC34A2) in the lung may induce abnormal alveolar type II (AT II) cells to transform into lung adenocarcinoma cells, and may also be important in biological process of lung adenocarcinoma. However, at present, the effects and molecular mechanisms of SLC34A2 in the initiation and progression of lung cancer remain to be elucidated. To the best of our knowledge, the present study revealed for the first time that the expression levels of SLC34A2 were downregulated in the A549 and H1299 lung adenocarcinoma cell lines. Further investigation demonstrated that the elevated expression of SLC34A2 in A549 cells was able to significantly inhibit cell viability and invasion in vitro. In addition, 10 upregulated genes between the A549‑P‑S cell line stably expressing SLC34A2 and the control cell line A549‑P were identified by microarray analysis and quantitative polymerase chain reaction, including seven tumor suppressor genes and three complement genes. Furthermore, the upregulation of complement gene C3 and complement 4B preproprotein (C4b) in A549‑P‑S cells was confirmed by ELISA analysis and was identified to be correlated with recovering Pi absorption in A549 cells by the phosphomolybdic acid method by enhancing the expression of SLC34A2. Therefore, it was hypothesized that the mechanisms underlying the effect of SLC34A2 on A549 cells might be associated with the activation of the complement alternative pathway (C3 and C4b) and upregulation of the expression of selenium binding protein 1, thioredoxin‑interacting protein, PDZK1‑interacting protein 1 and dual specificity protein phosphatase 6. Downregulation of SLC34A2 may primarily cause abnormal AT II cells to escape from complement‑associated immunosurveillance and abnormally express certain tumor‑suppressor genes inducing AT II cells to develop into lung adenocarcinoma. The present study further elucidated the effects and mechanisms of SLC34A2 in the generation and development of lung cancer." @default.
• W2083790519 created "2016-06-24" @default.
• W2083790519 creator A5009921747 @default.
• W2083790519 creator A5015448224 @default.
• W2083790519 creator A5029557188 @default.
• W2083790519 creator A5032929495 @default.
• W2083790519 creator A5044934330 @default.
• W2083790519 creator A5051765654 @default.
• W2083790519 creator A5080431093 @default.
• W2083790519 creator A5084149253 @default.
• W2083790519 creator A5090870832 @default.
• W2083790519 date "2014-07-14" @default.
• W2083790519 modified "2023-09-27" @default.
• W2083790519 title "Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells" @default.
• W2083790519 cites W1505246271 @default.
• W2083790519 cites W1536315000 @default.
• W2083790519 cites W1758249473 @default.
• W2083790519 cites W1810651552 @default.
• W2083790519 cites W1932276950 @default.
• W2083790519 cites W1964964549 @default.
• W2083790519 cites W1967426699 @default.
• W2083790519 cites W1971928855 @default.
• W2083790519 cites W1975155171 @default.
• W2083790519 cites W1978875738 @default.
• W2083790519 cites W1979697480 @default.
• W2083790519 cites W1983082245 @default.
• W2083790519 cites W2018584780 @default.
• W2083790519 cites W2019322535 @default.
• W2083790519 cites W2037390393 @default.
• W2083790519 cites W2037926018 @default.
• W2083790519 cites W2037949612 @default.
• W2083790519 cites W2042841392 @default.
• W2083790519 cites W2046878463 @default.
• W2083790519 cites W2048950527 @default.
• W2083790519 cites W2054023787 @default.
• W2083790519 cites W2059944938 @default.
• W2083790519 cites W2063894452 @default.
• W2083790519 cites W2064290355 @default.
• W2083790519 cites W2066378783 @default.
• W2083790519 cites W2078627116 @default.
• W2083790519 cites W2079994292 @default.
• W2083790519 cites W2080109450 @default.
• W2083790519 cites W2087550577 @default.
• W2083790519 cites W2091959096 @default.
• W2083790519 cites W2096249684 @default.
• W2083790519 cites W2101326169 @default.
• W2083790519 cites W2101995865 @default.
• W2083790519 cites W2105902643 @default.
• W2083790519 cites W2106146395 @default.
• W2083790519 cites W2107364222 @default.
• W2083790519 cites W2110289791 @default.
• W2083790519 cites W2112942368 @default.
• W2083790519 cites W2114930069 @default.
• W2083790519 cites W2128402413 @default.
• W2083790519 cites W2153598131 @default.
• W2083790519 cites W2158951820 @default.
• W2083790519 cites W2165472189 @default.
• W2083790519 cites W2172064884 @default.
• W2083790519 cites W2185154346 @default.
• W2083790519 cites W2294227944 @default.
• W2083790519 cites W2313368321 @default.
• W2083790519 cites W2440004261 @default.
• W2083790519 cites W2049256353 @default.
• W2083790519 doi "https://doi.org/10.3892/mmr.2014.2376" @default.
• W2083790519 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4121420" @default.
• W2083790519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25017204" @default.
• W2083790519 hasPublicationYear "2014" @default.
• W2083790519 type Work @default.
• W2083790519 sameAs 2083790519 @default.
• W2083790519 citedByCount "19" @default.
• W2083790519 countsByYear W20837905192015 @default.
• W2083790519 countsByYear W20837905192016 @default.
• W2083790519 countsByYear W20837905192017 @default.
• W2083790519 countsByYear W20837905192018 @default.
• W2083790519 countsByYear W20837905192019 @default.
• W2083790519 countsByYear W20837905192020 @default.
• W2083790519 countsByYear W20837905192021 @default.
• W2083790519 countsByYear W20837905192022 @default.
• W2083790519 countsByYear W20837905192023 @default.
• W2083790519 crossrefType "journal-article" @default.
• W2083790519 hasAuthorship W2083790519A5009921747 @default.
• W2083790519 hasAuthorship W2083790519A5015448224 @default.
• W2083790519 hasAuthorship W2083790519A5029557188 @default.
• W2083790519 hasAuthorship W2083790519A5032929495 @default.
• W2083790519 hasAuthorship W2083790519A5044934330 @default.
• W2083790519 hasAuthorship W2083790519A5051765654 @default.
• W2083790519 hasAuthorship W2083790519A5080431093 @default.
• W2083790519 hasAuthorship W2083790519A5084149253 @default.
• W2083790519 hasAuthorship W2083790519A5090870832 @default.
• W2083790519 hasBestOaLocation W20837905191 @default.
• W2083790519 hasConcept C104317684 @default.
• W2083790519 hasConcept C127561419 @default.
• W2083790519 hasConcept C1491633281 @default.
• W2083790519 hasConcept C153911025 @default.
• W2083790519 hasConcept C29537977 @default.
• W2083790519 hasConcept C502942594 @default.
• W2083790519 hasConcept C53227056 @default.
• W2083790519 hasConcept C54355233 @default.

• next